¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Chlorpheniramine/ Methscopolamine/ Phenylephrine Suspension"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chlorpheniramine
    Ŭ·Î¸£Æä´Ï¶ó¹Î
  • aqueous suspension
    ¼ö¼ººÎÀ¯¾×
  • brow suspension
    ´«½ç°É±â
  • liquid suspension
    ¾×üºÎÀ¯¾×
  • suspension
    1. °É±â, Çö¼ö 2. ÇöŹ 3. Çöʾ×, ºÎÀ¯¾× 4. ¼­½ºÆæ¼Ç
  • suspension culture
    Çöʹè¾ç, ºÎÀ¯¹è¾ç
  • suspension laryngoscope
    Çö¼öÈĵΰæ, °É±âÈĵκ¸°³
  • suspension laryngoscopy
    Çö¼öÈĵΰæ°Ë»ç(¹ý), °É±âÈĵκ¸°³°Ë»ç(¹ý), µÎ¼ÕÀÚÀ¯Èĵΰæ°Ë»ç
  • suspension method
    ºÎÀ¯¹°¹ý
  • suspension polymerization
    ºÎÀ¯ÁßÇÕ
  • suspension stability
    ÇöʾÈÁ¤¼º
  • urethral suspension operation
    ¿äµµ°É±â¼ö¼ú
  • urethrovesical suspension
    ¹æ±¤¿äµµ°É±â
  • vesicourethral suspension
    ¹æ±¤¿äµµ°É±â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suspension
    1.ºÎÀ¯¾×, 2.°É±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chlorpheniramine
    Ŭ·Î¸£Æä´Ï¶ó¹Î
  • aqueous suspension
    ¼ö¼ººÎÀ¯¾×
  • brow suspension
    ´«½ç°É±â
  • craniofacial suspension
    ¸Ó¸®¾ó±¼¸Å´Þ±â, µÎ°³¾È¸éÇö¼ö
  • suspension culture
    Çöʹè¾ç, ºÎÀ¯¹è¾ç
  • liquid suspension
    ¾×üºÎÀ¯¾×
  • suspension laryngoscope
    Çö¼öÈĵΰæ, °É±âÈĵκ¸°³
  • suspension laryngoscopy
    Çö¼öÈĵΰæ°Ë»ç(¹ý), °É±âÈĵκ¸°³°Ë»ç(¹ý), µÎ¼ÕÀÚÀ¯Èĵΰæ°Ë»ç
  • suspension method
    ¸Å´Þ±â, ¶ç¿ì±â
  • urethral suspension operation
    ¿äµµ°É±â¼ö¼ú
  • suspension polymerization
    ºÎÀ¯ÁßÇÕ
  • suspension
    ºÎÀ¯¾×, °É±â
  • static suspension
    Á¤Àû°É±â
  • suction suspension
    ÈíÀκÎÀ¯¾×, ÈíÀκÎÀ¯¾×ÀåÄ¡
  • suspension stability
    ÇöʾÈÁ¤¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aqueous suspension
    ¼ö¼ºÇöʾ×(â©àõúãöúäû)
  • phenylephrine hydrochloride
    ¿°»êÆä´Ò ¿¡ÇÁ¸°.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phenylephrine
  • phenylephrine hydrochloride
    ¿°»êÆä´Ò ¿¡ÇÁ¸°.
  • aqueous suspension
    ¼ö¼ºÇöʾ×(â©àõúãöúäû)
  • bladder neck suspension procedure
    ¹æ±¤°æºÎ Çö¼ö ¼ö¹ý
  • culture, suspension
    ºÎÀ¯¹è¾ç
  • insulin zinc suspension
    Àν¶¸°¾Æ¿¬Çöʾ×.
  • laryngoscopy, suspension
    Çö¼öÈĵΰæ°Ë»ç(¹ý)
  • liquid suspension
    ¾×üÇöʾ×<--ºÎÀ¯¾×>
  • nitrosulfathiazole suspension
    ÆÄ¶ó´ÏÆ®·Î¼úÆÄƼ¾ÆÁ¹ÇöŹÁ¦(~úØöúð¥).
  • oily suspension
    À¯ÇöŹ.
  • ophthalmic suspension
    ¾È°ú¿ë Çöʾ×Á¦(¡­úØöúäûð¥).
  • single cell suspension
    ´Ü¼¼Æ÷ºÎÀ¯¾× (¡­Ý©ë´äû).
  • suspension
    Çöʾ×(úØöúäû), ºÎÀ¯¾× (Ý©ë´äû).
  • suspension cell culture
    ¼¼Æ÷Çöʹè¾ç(á¬øà úØöúÛÆå×).
  • suspension culture
    Çöʹè¾ç(úØöúÛÆå×), ºÎ À¯¹è¾ç(Ý©ë´ÛÆå×).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suspension
    ÇöŹ(¾×) (úØöú(äû))
  • suspension culture
    Çöʹè¾ç (úØöúÛÆå×)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suspension
    Çöʾ×, ºÎÀ¯¾×
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CPM central pontine myelinosis; chlorpheniramine maleate; continuous passive motion; critical path metho...
PE Edinburgh Pharmacopoeia; pancreatic extract; paper electrophoresis; partial epilepsy; pelvic examina...
PHE periodic health examination; phenylephrine
NPH   1) Neutral Protamine Hagedorn Insulin
    = Isophane Insulin Susp...
AS acetylstrophanthidin; acidified serum; acoustic schwannoma; acoustic stimulation; active sarcoidosis...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CPM Chlorpheniramine maleate
PE Phenylephrine
PHE Phenylephrine
HS Hindlimb suspension
PSIFT Platelet Suspension Immunofluorescence Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • phenylephrine hydrochloride
    ¿°»ê Æä´Ò¿¡¸°
  • colloid suspension
    ÄÝ·ÎÀ̵å Çöʾ×
  • insulin zinc suspension
    Àν¶¸° ¾Æ¿¬ Çöʾ×
  • nystatin suspension
    ´Ï½ºÅ¸Æ¾ Çöʾ×
    C46H77NO19.
  • suspension cell culture
    ¼¼Æ÷ ÇöŹ ¹è¾ç
  • suspension wire fixation
    Çö¼ö °­¼± °íÁ¤
  • viable cell suspension
    »ý¼¼Æ÷ ºÎÀ¯¾×
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
methscopolamine bromide Epoxytropine tropate methylbromide;a parasympatholytic drug similar to atropine; the methyl nitrate has the same action and uses.
(05 Mar 2000)
chlorpheniramine <chemical> A histamine h1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than promethazine.
Pharmacological action: anti-allergic agents, antipruritics, histamine h1 antagonists.
Chemical name: 2-Pyridinepropanamine, gamma-(4-chlorophenyl)-N,N-dimethyl-
(12 Dec 1998)
chlorpheniramine maleate (&plusmn;)-2-[p-Chloro-alpha-[2-(dimethylamino)ethyl]benzyl]pyridine maleate;an antihistamine.
(05 Mar 2000)
phenylephrine <chemical> An alpha-adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent.
Pharmacological action: adrenergic alpha-agonists, cardiotonic agent, mydriatics, nasal decongestants, sympathomimetic, vasoconstrictor agents.
Chemical name: Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)-
(12 Dec 1998)
phenylephrine hydrochloride <drug> An alpha 1 adrenergic agonist.
(15 Oct 1997)
amorphous insulin zinc suspension Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection.
Synonym: amorphous insulin zinc suspension, semilente insulin.
(05 Mar 2000)
magnesia and alumina oral suspension A mixture of magnesium hydroxide and variable amounts of aluminum oxide; used as an antacid.
(05 Mar 2000)
chromic phosphate P 32 colloidal suspension A pure beta-emitting colloidal, nonabsorbable radiopharmaceutical administered into body cavities such as the pleural or peritoneal spaces to control malignant effusions.
See: sodium phosphate P 32.
(05 Mar 2000)
Coffey suspension <procedure, surgery> An operative technique following partial excision of the cornu, as in salpingectomy, whereby the broad and the round ligament are sutured over the cornual wound to restore continuity of the peritoneum and to suspend the uterus on the operated side.
(05 Mar 2000)
craniofacial suspension wiring A method of wiring using areas of bones not contiguous with the oral cavity for the support of fractured jaw segments (e.g., pyriform aperture, zygomatic arch, zygomatic process of the frontal bone).
(05 Mar 2000)
crystalline insulin zinc suspension A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours.
Synonym: crystalline insulin zinc suspension.
(05 Mar 2000)
prompt insulin zinc suspension Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection.
Synonym: amorphous insulin zinc suspension, semilente insulin.
(05 Mar 2000)
Sayre's suspension apparatus Archaic term for Sayre's suspension traction.
(05 Mar 2000)
Sayre's suspension traction Spinal traction obtained by vertical suspension of the patient by means of a head halter.
(05 Mar 2000)
hindlimb suspension Technique for limiting use, activity, or movement by immobilizing or restraining animal by suspending from hindlimbs or tails. This immobilization is used to simulate some effects of reduced gravity and study weightlessness physiology.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suspension
    ¸Å´Þ±â; ºÎÇ¥; ¹Ì°á; Á¤ÇÐ; ÁßÁö
  • suspension
    ¸Å´à;¸Å´Þ¸²;¸Å´Ù´Â ÁöÁÖ;(Ư±ÇÀÇ)ÀϽÃÁ¤Áö;Á¤Á÷;ÁßÁö;ÁöºÒÁ¤Áö;Â÷ü ¹öÆÃÀåÄ¡;ºÎÀ¯(»óÅÂ);Çöʾ×
  • suspension bridge
    Àû±³
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á